Video is available - Log in to view. You must be registered to the event to view content
For attending this session, you can claim 1.5 EACCME credits
After this session, the participants should be able to:
- Be aware how to personalize IS using pharmacogenomics
- Know the list ofimmunosuppresives drugs present in the pipeline
- Be aware of various ways tomanage IS when a cancer is diagnosed
Dr. Pamala A Jacobson, United States
Pharmacogenomics: a promise of personalized medication management
Dr. Ilkka Helantera, Finland
The immunosuppressive therapy pipeline: what is really out there?
Prof. Rachel Hellemans, Belgium
Managing the post-transplant patient with cancer: is there a right or wrong approach? (should include discussion of check point inhibitors)
